TY - JOUR
T1 - TIPICO X
T2 - report of the 10th interactive infectious disease workshop on infectious diseases and vaccines
AU - Rivero-Calle, Irene
AU - Gómez-Rial, Jose
AU - Bont, Louis
AU - Gessner, Bradford D.
AU - Kohn, Melvin
AU - Dagan, Ron
AU - Payne, Daniel C.
AU - Bruni, Laia
AU - Pollard, Andrew J.
AU - García-Sastre, Adolfo
AU - Faustman, Denise L.
AU - Osterhaus, Albert
AU - Butler, Robb
AU - Giménez Sánchez, Francisco
AU - Álvarez, Francisco
AU - Kaforou, Myrsini
AU - Bello, Xabier
AU - Martinón-Torres, Federico
N1 - Publisher Copyright:
© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.
PY - 2021/1/1
Y1 - 2021/1/1
N2 - TIPICO is an expert meeting and workshop that aims to provide the most recent evidence in the field of infectious diseases and vaccination. The 10th Interactive Infectious Disease TIPICO workshop took place in Santiago de Compostela, Spain, on November 21–22, 2019. Cutting-edge advances in vaccination against respiratory syncytial virus, Streptococcus pneumoniae, rotavirus, human papillomavirus, Neisseria meningitidis, influenza virus, and Salmonella Typhi were discussed. Furthermore, heterologous vaccine effects were updated, including the use of Bacillus Calmette-Guérin (BCG) vaccine as potential treatment for type 1 diabetes. Finally, the workshop also included presentations and discussion on emergent virus and zoonoses, vaccine resilience, building and sustaining confidence in vaccination, approaches to vaccine decision-making, pros and cons of compulsory vaccination, the latest advances in decoding infectious diseases by RNA gene signatures, and the application of big data approaches.
AB - TIPICO is an expert meeting and workshop that aims to provide the most recent evidence in the field of infectious diseases and vaccination. The 10th Interactive Infectious Disease TIPICO workshop took place in Santiago de Compostela, Spain, on November 21–22, 2019. Cutting-edge advances in vaccination against respiratory syncytial virus, Streptococcus pneumoniae, rotavirus, human papillomavirus, Neisseria meningitidis, influenza virus, and Salmonella Typhi were discussed. Furthermore, heterologous vaccine effects were updated, including the use of Bacillus Calmette-Guérin (BCG) vaccine as potential treatment for type 1 diabetes. Finally, the workshop also included presentations and discussion on emergent virus and zoonoses, vaccine resilience, building and sustaining confidence in vaccination, approaches to vaccine decision-making, pros and cons of compulsory vaccination, the latest advances in decoding infectious diseases by RNA gene signatures, and the application of big data approaches.
KW - Infectious disease
KW - RNA gene signatures
KW - big data
KW - emergent virus
KW - off-target effects
KW - transcriptomics
KW - vaccine hesitancy
KW - vaccine resilience
KW - vaccine-preventable diseases
KW - zoonoses
UR - http://www.scopus.com/inward/record.url?scp=85089153543&partnerID=8YFLogxK
U2 - 10.1080/21645515.2020.1788301
DO - 10.1080/21645515.2020.1788301
M3 - Article
C2 - 32755474
AN - SCOPUS:85089153543
SN - 2164-5515
VL - 17
SP - 759
EP - 772
JO - Human Vaccines and Immunotherapeutics
JF - Human Vaccines and Immunotherapeutics
IS - 3
ER -
